Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by FactFinder1994on Jan 28, 2021 8:13am
163 Views
Post# 32407379

Science Quality Innovation

Science Quality InnovationWith three shots on goal over weeks ahead and FDA approving submissions for EUA, what is not to like!  

1) What do you think the chances of approval are for a Covid-19 Antibody test that delivers greater than 99% accuracy in 24 hours? 
2) RALI-dx Covid-19 Severity/Triage test that delivers results of 5 key biomarkers in under an hour.  
3) RALI-fast measures IL-6, the most informative cytokine biomarker predicting adverse path (cytokine storm) probability in under 15 minutes.  
 
Each Approval on its own is worth more than SQI's present value.  There is much to be excitied about.  SQI has a bright future, and will make a significant different in hospitals, and ultimately lives.      
 
Science Quality Innovation (SQI).  
 
Stay Tuned 
<< Previous
Bullboard Posts
Next >>